These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12186421)

  • 21. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes.
    Niwa T; Yamamoto S; Saito M; Shiraga T; Takagi A
    Yakugaku Zasshi; 2007 Jan; 127(1):209-16. PubMed ID: 17202802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
    Misaka S; Kawabe K; Onoue S; Werba JP; Giroli M; Tamaki S; Kan T; Kimura J; Watanabe H; Yamada S
    Drug Metab Pharmacokinet; 2013; 28(3):244-9. PubMed ID: 23268924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.
    Chauret N; Gauthier A; Nicoll-Griffith DA
    Drug Metab Dispos; 1998 Jan; 26(1):1-4. PubMed ID: 9443844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans.
    Echizen H; Tanizaki M; Tatsuno J; Chiba K; Berwick T; Tani M; Gonzalez FJ; Ishizaki T
    Drug Metab Dispos; 2000 Aug; 28(8):937-44. PubMed ID: 10901704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
    Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
    Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
    Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A
    Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Jeong HU; Lee HS
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4'-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6beta-hydroxylation.
    Easterbrook J; Fackett D; Li AP
    Chem Biol Interact; 2001 May; 134(3):243-9. PubMed ID: 11336973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
    Jeong HU; Kong TY; Kwon SS; Hong SW; Yeon SH; Choi JH; Lee JY; Cho YY; Lee HS
    Molecules; 2013 Sep; 18(9):10681-93. PubMed ID: 24005963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of selected platinum(II) complexes containing roscovitine-based CDK inhibitors as ligands with human liver microsomal cytochrome P450.
    Masek V; Starha P; Harvanova M; Michalova M; Milde D; Travnicek Z; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):382-7. PubMed ID: 25004912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes.
    Bellec G; Dréano Y; Lozach P; Ménez JF; Berthou F
    Carcinogenesis; 1996 Sep; 17(9):2029-34. PubMed ID: 8824531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
    Shimada T; Tsumura F; Yamazaki H
    Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of serotonin-3 receptor antagonists on cytochrome P450 activities in human liver microsomes.
    Niwa T; Yamamoto S; Saito M; Kobayashi N; Ikeda K; Noda Y; Takagi A
    Biol Pharm Bull; 2006 Sep; 29(9):1931-5. PubMed ID: 16946512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential of Hypoxis hemerocallidea for herb-drug interaction.
    Fasinu PS; Gutmann H; Schiller H; Bouic PJ; Rosenkranz B
    Pharm Biol; 2013 Dec; 51(12):1499-507. PubMed ID: 23844611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.